15/09/2009 - 11:13

BioPharmica plans IPO for subsidiary

15/09/2009 - 11:13

Bookmark

Save articles for future reference.

Perth-based biotechnology outfit BioPharmica plans to seek an initial public offer for its wholly owned subsidiary, Molecular Discovery Systems, which will focus on cancer treatments.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options